Developer of a medical technology designed to analyse cell and genome engineering. The company's medical technology specializes in cellular engineering and analysis based on the CRISPR-Cas9 technology platform which paired with a guide RNA, cuts double-stranded DNA and allows for specific changes to DNA, enabling development of therapeutics for agricultural biotechnology, industrial biotechnology and basic and applied biological research.
Generating Revenue
Privately Held (backing)
Venture Capital-Backed